A Phase I, Open-label, Multi-center Study of Clofarabine (JC0707) in Japanese Patients With Acute Myeloid Leukemia (AML).
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Clofarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Pharmacokinetics
- 17 May 2011 Planned end date changed from 1 May 2011 to 1 Apr 2011 as reported by ClinicalTrials.gov.
- 12 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2011 Planned End Date changed from 1 Jun 2011 to 1 May 2011 as reported by ClinicalTrials.gov.